Designer DNA nanocages modulate anti-oxidative and anti-inflammatory responses in tumor associated macrophages
Abstract
Cancer is a complex disease, with multiple treatment modalities, but no definitive cure. The tumor microenvironment contributes to the complexity of the disease by forming a niche of multiple cell types supporting each other to carry out various cellular functions. Tumor associated macrophages are one such kind of cells which support the tumor microenvironment via immunosuppression. DNA tetrahedron (TD), a widely explored DNA nanocage, has shown a lot of potential in therapeutics. However, the role of TD still remains quite unexplored in immunology. Here, we first establish the anti-oxidative and anti-inflammatory role of TD. We then proceed with using TD as a therapeutic agent in tumor associated macrophages by modulating the response of PD-L1. The findings of this work create a base for TD in biological applications such as cancer immunotherapy. Graphical AbstractImmunomodulatory effects of DNA nanocages on tumour associated macrophages O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/601504v1_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@10e585aorg.highwire.dtl.DTLVardef@ca91c4org.highwire.dtl.DTLVardef@12812a8org.highwire.dtl.DTLVardef@1e10880_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 3.91
- Field percentile
- top 5%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Immune Landscape of Tumor-Associated Macrophage Reprogramming
Florent Duval, João Lourenço, … Nahal Mansouri·bioRxiv·Sep 25, 2024
- ATM-mediated DNA damage response in macrophages primes phagocytosis and immune checkpoint regulation
A. Bansal, R. Neuhaus, … B. Schumacher·bioRxiv·Mar 14, 2020
- Harnessing the Cross-talk between Tumor Cells and Tumor-associated Macrophages with a Nano-drug for modulation of Glioblastoma Immune Microenvironment
T.-F. Li, K. Li, … X. Chen·Journal of Controlled ReleasePeer-reviewed·Dec 1, 2017
- A lymph node-to-tumour PD-L1+macrophage circuit antagonizes dendritic cell immunotherapy
J. Sprooten, I. Vanmeerbeek, … A. D. Garg·Cell Reports MedicinePeer-reviewed·Jan 1, 2024
- PD-L1 blockade restores CAR T cell activity through IFNγ-regulation of CD163+ macrophages
Y. Yamaguchi, J. Gibson, … S. J. Priceman·bioRxiv·Jan 25, 2022
- Critical role of CD206+ macrophages in promoting a cDC1-NK-CD8 T cell anti-tumor immune axis
A. Ray, K. H. Hu, … M. F. Krummel·bioRxiv·Oct 31, 2023